Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2019. For the half year, the company announced sales was CNY 419.493 million compared to CNY 428.133 million a year ago. Operating income was CNY 86.314 million compared to CNY 71.097 million a year ago. Net income was CNY 71.900 million compared to CNY 60.681 million a year ago. Basic earnings per share from continuing operations was CNY 0.1429 compared to CNY 0.1206 a year ago.